Fidelity Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $249K | Sell |
|
|||||
|
2023
Q3 | $66.6M | Buy |
|
|||||
|
2023
Q2 | $4.47M | Sell |
|
|||||
|
2023
Q1 | $6.62M | Sell |
|
|||||
|
2022
Q4 | $31.1M | Sell |
|
|||||
|
2022
Q3 | $150M | Buy |
|
|||||
|
2022
Q2 | $135M | Sell |
|
|||||
|
2022
Q1 | $193M | Sell |
|
|||||
|
2021
Q4 | $401M | Buy |
|
|||||
|
2021
Q3 | $469M | Sell |
|
|||||
|
2021
Q2 | $430M | Sell |
|
|||||
|
2021
Q1 | $477M | Buy |
|
|||||
|
2020
Q4 | $610M | Buy |
|
|||||
|
2020
Q3 | $413M | Buy |
|
|||||
|
2020
Q2 | $236M | Sell |
|
|||||
|
2020
Q1 | $213M | Buy |
|
|||||
|
2019
Q4 | $260M | Sell |
|
|||||
|
2019
Q3 | $171M | Sell |
|
|||||
|
2019
Q2 | $302M | Sell |
|
|||||
|
2019
Q1 | $338M | Buy |
|
|||||
|
2018
Q4 | $93.2M | Buy |
|
|||||
|
2018
Q3 | $100M | Buy |
|
|||||
|
2018
Q2 | $97.9M | Buy |
|
|||||
|
2018
Q1 | $36.4M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $8.7M | Sell |
|
|||||
|
2016
Q1 | $55.9M | Sell |
|
|||||
|
2015
Q4 | $91.3M | Buy |
|
|||||
|
2015
Q3 | $96M | Buy |
|
|||||
|
2015
Q2 | $76.3M | Hold |
|
|||||
|
2015
Q1 | $71.1M | Buy |
|
|||||
|
2014
Q4 | $24.3M | Buy |
|
|||||
|
2014
Q3 | $21.8M | Buy |
|
|||||
|
2014
Q2 | $24.3M | Sell |
|
|||||
|
2014
Q1 | $27.4M | Buy |
|
|||||
|
2013
Q4 | $12.2M | Buy |
|